Melek Aslan Kayıran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Melek Aslan Kayıran has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
- Ayse Serap Karadag
Department of Dermatology Memorial Atasehir Hospital Istanbul Turkey
12 shared publications Ayşe Serap Karadağ
Department of Dermatology and Venereology, Memorial Atasehir Hospital Istanbul Arel University Istanbul Turkey
7 shared publications- Hasan Aksoy
Department of Dermatology, Göztepe Prof. Dr. Suleyman Yalcin City Hospital, İstanbul, Turkey
7 shared publications - Filiz Cebeci Kahraman
Department of Dermatology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Turkey
6 shared publications Mehmet Salih Gürel
1İstanbul Medeniyet University, Göztepe Prof Dr. Süleyman Yalçın City Hospital, Department of Dermatological and Venereal Diseases
6 shared publicationsAsude Kara Polat
Department of Dermatology and Venereology, Istanbul Training and Research Hospital Health Sciences University Istanbul Turkey
5 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (1) , 5756
Digital Health Behavior in Chronic Spontaneous Urticaria: Internet and Social Media Use Patterns
Introduction: Chronic spontaneous urticaria (CSU) is a prevalent dermatological condition leading to frequent visits to primary care, emergency departments, and dermatology clinics worldwide. Its chronic relapsing nature, accompanied by angioedema, shortness of breath, and intense pruritus, drives patients to seek information and treatment. Objective: This study aimed to investigate CSU patients’ Internet usage habits, including their search terms , trusted sources, and whether they share this information with their physicians. Methods: A survey was conducted among 80 patients at a tertiary hospital’s urticaria outpatient clinic. Data collected included sociodemographic characteristics, urticaria activity scores, dermatology life quality indexes, and Internet and social media usage patterns related to CSU. Results: Of the 80 patients, 73.8% had researched CSU online, with significantly higher usage among younger, single patients with lower educational levels and shorter disease duration. Google was the most used platform (84.7%), followed by Instagram and YouTube (25.4% each). General information about CSU was the primary search term (76.3%). Notably, 21.3% attempted to contact doctors via social media, a behavior less common among patients using omalizumab. Approximately 75% did not share their findings with their physicians. Additionally, 58.8% expressed a desire for dermatologists to provide more online information about CSU. Conclusions: CSU patients frequently research their condition online but often conceal this from their doctors. Attempts to contact physicians via social media were lower among omalizumab users, possibly due to regular follow-ups. Enhancing dermatological follow-up and online educational resources could improve patient engagement and treatment adherence.
- 30 January 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (1) , 5756
Open AccessDigital Health Behavior in Chronic Spontaneous Urticaria: Internet and Social Media Use Patterns
Introduction: Chronic spontaneous urticaria (CSU) is a prevalent dermatological condition leading to frequent visits to primary care, emergency departments, and dermatology clinics worldwide. Its chronic relapsing nature, accompanied by angioedema, shortness of breath, and intense pruritus, drives patients to seek information and treatment. Objective: This study aimed to investigate CSU patients’ Internet usage habits, including their search terms , trusted sources, and whether they share this information with their physicians. Methods: A survey was conducted among 80 patients at a tertiary hospital’s urticaria outpatient clinic. Data collected included sociodemographic characteristics, urticaria activity scores, dermatology life quality indexes, and Internet and social media usage patterns related to CSU. Results: Of the 80 patients, 73.8% had researched CSU online, with significantly higher usage among younger, single patients with lower educational levels and shorter disease duration. Google was the most used platform (84.7%), followed by Instagram and YouTube (25.4% each). General information about CSU was the primary search term (76.3%). Notably, 21.3% attempted to contact doctors via social media, a behavior less common among patients using omalizumab. Approximately 75% did not share their findings with their physicians. Additionally, 58.8% expressed a desire for dermatologists to provide more online information about CSU. Conclusions: CSU patients frequently research their condition online but often conceal this from their doctors. Attempts to contact physicians via social media were lower among omalizumab users, possibly due to regular follow-ups. Enhancing dermatological follow-up and online educational resources could improve patient engagement and treatment adherence.
- Open Access
- 10 April 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (8) , 1409-1415
Self‐Induced Nail Disorders: Clinical and Demographical Features
Background: Self‐induced nail disorders (SINDs) are a subset of body‐focused repetitive behaviors (BFRBs) characterized by pathological grooming habits that damage the nail and periungual structures. These disorders were classified into subgroups based on the specific methods individuals use to harm their nails. Despite their prevalence and potential psychological impact, limited data exist. This study aims to investigate the demographic and clinical characteristics of SINDs.Methods: This multicenter prospective cohort study included 675 patients diagnosed with SINDs at dermatology outpatient clinics between February and June 2024. Data collected included demographic information, SIND subtypes, associated BFRBs, psychiatric history, and family history of BFRBs. Patients were categorized into six SIND subgroups. Approval from the ethical committee was obtained.Results: The mean age of SIND onset was 16.60 ± 10.61 years, with no significant gender difference (p = 0.195). Forty‐seven percent of patients belonged to more than one SIND subgroup, and 45.4% had other BFRBs, with cheek/lip biting (55.7%) and acne excoriée (44.9%) being the most common. Females exhibited higher rates of accompanying BFRBs (54.5% vs. 31.2%; p = 0.001). Patients rarely sought medical treatment (19.1%), even if they felt severe discomfort regarding their habit (56.0%). Patients with diagnosed psychiatric disorders or a family history of BFRBs were more likely to seek treatment (p = 0.001, p = 0.013).Conclusion: SINDs often coexist with other BFRBs, predominantly affecting females. While patients are frequently aware of their habits, the rate of seeking medical treatment remains low. Dermatologists play a vital role in identifying SINDs, addressing associated behaviors, and coordinating care for coexisting psychiatric conditions.
- 10 April 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (8) , 1409-1415
Open AccessSelf‐Induced Nail Disorders: Clinical and Demographical Features
Background: Self‐induced nail disorders (SINDs) are a subset of body‐focused repetitive behaviors (BFRBs) characterized by pathological grooming habits that damage the nail and periungual structures. These disorders were classified into subgroups based on the specific methods individuals use to harm their nails. Despite their prevalence and potential psychological impact, limited data exist. This study aims to investigate the demographic and clinical characteristics of SINDs.Methods: This multicenter prospective cohort study included 675 patients diagnosed with SINDs at dermatology outpatient clinics between February and June 2024. Data collected included demographic information, SIND subtypes, associated BFRBs, psychiatric history, and family history of BFRBs. Patients were categorized into six SIND subgroups. Approval from the ethical committee was obtained.Results: The mean age of SIND onset was 16.60 ± 10.61 years, with no significant gender difference (p = 0.195). Forty‐seven percent of patients belonged to more than one SIND subgroup, and 45.4% had other BFRBs, with cheek/lip biting (55.7%) and acne excoriée (44.9%) being the most common. Females exhibited higher rates of accompanying BFRBs (54.5% vs. 31.2%; p = 0.001). Patients rarely sought medical treatment (19.1%), even if they felt severe discomfort regarding their habit (56.0%). Patients with diagnosed psychiatric disorders or a family history of BFRBs were more likely to seek treatment (p = 0.001, p = 0.013).Conclusion: SINDs often coexist with other BFRBs, predominantly affecting females. While patients are frequently aware of their habits, the rate of seeking medical treatment remains low. Dermatologists play a vital role in identifying SINDs, addressing associated behaviors, and coordinating care for coexisting psychiatric conditions.
- Open Access
- 22 April 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (9) , 1193-1199
Biologic therapy increases Demodex density in psoriasis patients
Background: Demodex density is known to increase in various immunosuppressive conditions. The relationship between biologic therapy and Demodex density remains unknown. We aimed to investigate whether the density of Demodex mites is higher in psoriasis patients treated with biologic agents compared to treatment‐naive or topically treated patients.Methods: A cross‐sectional study was conducted, comparing psoriasis patients receiving biologic therapy (n = 34) with controls (n = 33). Demodex density was assessed using the standardized skin surface biopsy technique (SSSB). Statistical analysis was performed to compare the densities and prevalence of demodicosis between the two groups.Results: Demodex density was significantly higher in the biologic therapy group compared to the control group on the right cheek (7.29 vs. 0.12/cm2; P = 0.001), left cheek (8.15 vs. 0.24/cm2; P = 0.002), and whole face (average of all four regions: 5.50 vs. 0.80/cm2; P = 0.001). The prevalence of demodicosis was significantly higher in the biologic therapy group on the forehead (35.3% vs. 12.1%; P = 0.043), right cheek (41.2% vs. 0%; P < 0.001), and left cheek (44.1% vs. 0%; P < 0.001). The frequency of cases with demodicosis in at least one localization was higher in the biological therapy group compared to the control group (61.8% vs. 15.2%; P < 0.001).Conclusions: Psoriasis patients receiving biologic therapy had a higher Demodex density and prevalence of demodicosis compared to controls. Biologics may lead to an increase in Demodex density by blocking specific cytokines, such as interleukin‐17 and tumor necrosis factor‐α, which play a role in immunity against Demodex. Further research is needed to explore the impact of different biological agents on Demodex density.
- 22 April 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (9) , 1193-1199
Open AccessBiologic therapy increases Demodex density in psoriasis patients
Background: Demodex density is known to increase in various immunosuppressive conditions. The relationship between biologic therapy and Demodex density remains unknown. We aimed to investigate whether the density of Demodex mites is higher in psoriasis patients treated with biologic agents compared to treatment‐naive or topically treated patients.Methods: A cross‐sectional study was conducted, comparing psoriasis patients receiving biologic therapy (n = 34) with controls (n = 33). Demodex density was assessed using the standardized skin surface biopsy technique (SSSB). Statistical analysis was performed to compare the densities and prevalence of demodicosis between the two groups.Results: Demodex density was significantly higher in the biologic therapy group compared to the control group on the right cheek (7.29 vs. 0.12/cm2; P = 0.001), left cheek (8.15 vs. 0.24/cm2; P = 0.002), and whole face (average of all four regions: 5.50 vs. 0.80/cm2; P = 0.001). The prevalence of demodicosis was significantly higher in the biologic therapy group on the forehead (35.3% vs. 12.1%; P = 0.043), right cheek (41.2% vs. 0%; P < 0.001), and left cheek (44.1% vs. 0%; P < 0.001). The frequency of cases with demodicosis in at least one localization was higher in the biological therapy group compared to the control group (61.8% vs. 15.2%; P < 0.001).Conclusions: Psoriasis patients receiving biologic therapy had a higher Demodex density and prevalence of demodicosis compared to controls. Biologics may lead to an increase in Demodex density by blocking specific cytokines, such as interleukin‐17 and tumor necrosis factor‐α, which play a role in immunity against Demodex. Further research is needed to explore the impact of different biological agents on Demodex density.
- Open Access
- 29 February 2024
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 34 (1) , 124-129
Comparison of Physicians’ Perceptions Regarding Dermatological Diseases
Background/Aims: Physicians frequently encounter skin diseases and provide opinions to their patients regarding dermatology. We aimed to assess the perceptions of physicians regarding skin diseases and to compare dermatologists’ and non-dermatologist physicians’ understanding of specific dermatological issues. Methods: Through an online form, participants were asked to respond to sentences indicating whether skin diseases are related to the liver or food with options such as "almost always," "mostly," "half-and-half," "less often," and "almost never." Similarly, they were asked to respond to sentences related to avoiding isotretinoin treatment and performing allergy tests in acute urticaria with options as "strongly disagree," "disagree," "partly agree," "agree," and "strongly agree." Statistical analysis was performed using Statistical Package for the Social Sciences v.27. Results: The sentences “skin diseases are of liver origin” and “skin diseases are caused by foods/drinks” received responses of “almost never” or “less often” at a rate of 91.8% and 80.9%, respectively. The total proportions of participants who selected “strongly agree,” “agree,” or “partly agree” were 53.9% for the statement restricting isotretinoin use and 45.5% for the statement recommending allergy testing in acute urticaria. While 91.8% of dermatologists disagreed with the statement limiting isotretinoin use, 68.3% of non-dermatologist physicians partially or completely agreed. For the statement recommending allergy testing in acute urticaria, 85.8% of dermatologists disagreed, while 55.7% of non-dermatologist physicians partially or completely agreed. Conclusions: The popular belief that skin diseases are caused by the liver or food has no basis among physicians. However, contrary to the literature, non-dermatologist physicians have expressed opinions that isotretinoin should be used as little as possible due to potential harm to the liver and that allergy tests should be performed in cases of acute urticaria. Giving importance to these topics during medical education will contribute to changing physicians' perspectives and ultimately benefit public health.
- 29 February 2024
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 34 (1) , 124-129
Open AccessComparison of Physicians’ Perceptions Regarding Dermatological Diseases
Background/Aims: Physicians frequently encounter skin diseases and provide opinions to their patients regarding dermatology. We aimed to assess the perceptions of physicians regarding skin diseases and to compare dermatologists’ and non-dermatologist physicians’ understanding of specific dermatological issues. Methods: Through an online form, participants were asked to respond to sentences indicating whether skin diseases are related to the liver or food with options such as "almost always," "mostly," "half-and-half," "less often," and "almost never." Similarly, they were asked to respond to sentences related to avoiding isotretinoin treatment and performing allergy tests in acute urticaria with options as "strongly disagree," "disagree," "partly agree," "agree," and "strongly agree." Statistical analysis was performed using Statistical Package for the Social Sciences v.27. Results: The sentences “skin diseases are of liver origin” and “skin diseases are caused by foods/drinks” received responses of “almost never” or “less often” at a rate of 91.8% and 80.9%, respectively. The total proportions of participants who selected “strongly agree,” “agree,” or “partly agree” were 53.9% for the statement restricting isotretinoin use and 45.5% for the statement recommending allergy testing in acute urticaria. While 91.8% of dermatologists disagreed with the statement limiting isotretinoin use, 68.3% of non-dermatologist physicians partially or completely agreed. For the statement recommending allergy testing in acute urticaria, 85.8% of dermatologists disagreed, while 55.7% of non-dermatologist physicians partially or completely agreed. Conclusions: The popular belief that skin diseases are caused by the liver or food has no basis among physicians. However, contrary to the literature, non-dermatologist physicians have expressed opinions that isotretinoin should be used as little as possible due to potential harm to the liver and that allergy tests should be performed in cases of acute urticaria. Giving importance to these topics during medical education will contribute to changing physicians' perspectives and ultimately benefit public health.
- 18 January 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (2) , 201-206
The effect of phototherapy on Demodex density: a case–control study
Background: Human Demodex mites,Demodex folliculorumandDemodex brevis, are microorganisms that reside in the pilosebaceous units, usually without causing symptoms. Phototherapy has been linked to demodicosis in previous studies. We aimed to determine whether there was an increase in the frequency of demodicosis and Demodex density after 20 phototherapy sessions.Methods: A case–control study was conducted with 32 participants who received narrowband ultraviolet B or ultraviolet A‐1 therapy for various dermatological indications. Standardized skin surface biopsies were performed before and after phototherapy to assess Demodex density. The presence of Demodex‐related skin conditions was assessed before phototherapy. A statistical analysis was performed to compare the Demodex densities and prevalence of demodicosis between the baseline and 20th session of phototherapy.Results: No significant change was observed in Demodex density after 20 sessions of phototherapy. The average Demodex density before treatment was 2.75 ± 4.48 (/cm2), and after treatment, it was 2.85 ± 4.81 (/cm2), indicating no significant difference (P = 0.879). The percentage of patients with demodicosis in at least one region of the face was 28.1% (9/32) before treatment, and after treatment, it was 31.3% (10/32), with no significant difference (P = 1.00).Conclusions: Our findings contradict previous studies that suggested an increased Demodex density and demodicosis prevalence after phototherapy. The data from previous studies are open to debate due to their selected samples, designs, and interpretations regarding the phototherapy–immunosuppression–Demodex relationship. Larger‐scale longitudinal studies conducted on a homogeneous sample are warranted to better understand the relationship between phototherapy and demodicosis.
- 18 January 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (2) , 201-206
The effect of phototherapy on Demodex density: a case–control study
Background: Human Demodex mites,Demodex folliculorumandDemodex brevis, are microorganisms that reside in the pilosebaceous units, usually without causing symptoms. Phototherapy has been linked to demodicosis in previous studies. We aimed to determine whether there was an increase in the frequency of demodicosis and Demodex density after 20 phototherapy sessions.Methods: A case–control study was conducted with 32 participants who received narrowband ultraviolet B or ultraviolet A‐1 therapy for various dermatological indications. Standardized skin surface biopsies were performed before and after phototherapy to assess Demodex density. The presence of Demodex‐related skin conditions was assessed before phototherapy. A statistical analysis was performed to compare the Demodex densities and prevalence of demodicosis between the baseline and 20th session of phototherapy.Results: No significant change was observed in Demodex density after 20 sessions of phototherapy. The average Demodex density before treatment was 2.75 ± 4.48 (/cm2), and after treatment, it was 2.85 ± 4.81 (/cm2), indicating no significant difference (P = 0.879). The percentage of patients with demodicosis in at least one region of the face was 28.1% (9/32) before treatment, and after treatment, it was 31.3% (10/32), with no significant difference (P = 1.00).Conclusions: Our findings contradict previous studies that suggested an increased Demodex density and demodicosis prevalence after phototherapy. The data from previous studies are open to debate due to their selected samples, designs, and interpretations regarding the phototherapy–immunosuppression–Demodex relationship. Larger‐scale longitudinal studies conducted on a homogeneous sample are warranted to better understand the relationship between phototherapy and demodicosis.
- Open Access
- 17 October 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 961-963
Dermoscopic Diagnosis of a Non-Pigmented Skin Tumor: Eccrine Poroma
Dear Editor, Eccrine poroma stands as a benign adnexal neoplasm that originates from the acrosyringium. It typically emerges as solitary, flesh-colored, or erythematous papules, plaques, or nodules, primarily appearing in areas with sweat glands. As well as pigmented lesions, dermoscopy has proven to enhance the clinical diagnosis of numerous non-pigmented skin tumors, including eccrine poroma. Herein we present a case of eccrine poroma located on the dorsal aspect of the left foot, with characteristic dermoscopic features. A 60-year-old woman was admitted with an asymptomatic lesion on the dorsum of her left foot, which had manifested approximately four years before. Clinically, the lesion presented as a well-circumscribed, violaceous, 0.9x0.9 cm papule (Figure 1a). Dermoscopic examination revealed flower-like and leaf-like vascular patterns, white interlacing areas, glomerular vessels, and milky red globules (Figures 1c-d). The lesion was excised and histopathologic findings were consistent with eccrine poroma (Figure 1b). Eccrine poroma (EP) is an adnexal tumor originating in the intraepidermal part of the eccrine sweat gland duct. Dermoscopy and histopathology help to differentiate EP from pyogenic granuloma, seborrheic keratosis, verruca vulgaris, basal cell carcinoma, squamous cell carcinoma, and amelanotic melanoma. Well-defined dermoscopic features in EP are: White interlacing areas around vessels, milky-red globules, flower-like and leaf-like vascular patterns, glomerular vessels, hairpin vessels, yellow structureless areas, poorly visualized vessels, and well-circumscribed globular or lacuna-like structures separated by white to pink mesh bands [1-3]. Histologically, EP manifests as a well-contained tumor constituted of proliferative cuboidal or poroid cells, often extending from the basal epidermis into the dermal layer. Shave, electrosurgical destruction or simple excision may be the treatment of lesions, depending on the depth of the lesion. Kind Regards
- 17 October 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 961-963
Open AccessDermoscopic Diagnosis of a Non-Pigmented Skin Tumor: Eccrine Poroma
Dear Editor, Eccrine poroma stands as a benign adnexal neoplasm that originates from the acrosyringium. It typically emerges as solitary, flesh-colored, or erythematous papules, plaques, or nodules, primarily appearing in areas with sweat glands. As well as pigmented lesions, dermoscopy has proven to enhance the clinical diagnosis of numerous non-pigmented skin tumors, including eccrine poroma. Herein we present a case of eccrine poroma located on the dorsal aspect of the left foot, with characteristic dermoscopic features. A 60-year-old woman was admitted with an asymptomatic lesion on the dorsum of her left foot, which had manifested approximately four years before. Clinically, the lesion presented as a well-circumscribed, violaceous, 0.9x0.9 cm papule (Figure 1a). Dermoscopic examination revealed flower-like and leaf-like vascular patterns, white interlacing areas, glomerular vessels, and milky red globules (Figures 1c-d). The lesion was excised and histopathologic findings were consistent with eccrine poroma (Figure 1b). Eccrine poroma (EP) is an adnexal tumor originating in the intraepidermal part of the eccrine sweat gland duct. Dermoscopy and histopathology help to differentiate EP from pyogenic granuloma, seborrheic keratosis, verruca vulgaris, basal cell carcinoma, squamous cell carcinoma, and amelanotic melanoma. Well-defined dermoscopic features in EP are: White interlacing areas around vessels, milky-red globules, flower-like and leaf-like vascular patterns, glomerular vessels, hairpin vessels, yellow structureless areas, poorly visualized vessels, and well-circumscribed globular or lacuna-like structures separated by white to pink mesh bands [1-3]. Histologically, EP manifests as a well-contained tumor constituted of proliferative cuboidal or poroid cells, often extending from the basal epidermis into the dermal layer. Shave, electrosurgical destruction or simple excision may be the treatment of lesions, depending on the depth of the lesion. Kind Regards
- Open Access
- 4 October 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 712-720
Comparison of Topical Treatment Preferences of Physicians in Dermatological Diseases
Objective: Regardless of their specialty, physicians frequently encounter dermatological conditions. We aimed to determine the topical medication choices of physicians for various dermatoses and to identify differences in preferences between dermatologists and non-dermatologist physicians. Methods: Using an online survey, physicians were asked to select three preferred topical antibiotics/antiseptics, antifungals, and corticosteroids when treating a pyoderma, dermatophytosis, or a dermatosis necessitating topical corticosteroid therapy. Statistical analysis was performed using Statistical Package for the Social Sciences v.27. Results: Among 358 physicians, 24.0% were dermatologists, and 76.0% were non-dermatologist physicians. The mean age was 38.40, and the average duration of medical practice was 14.04 years. The most frequently chosen topical antibacterials were fusidic acid (74.3%) and mupirocin (65.9%); topical antifungals were isoconazole nitrate + diflucortolone valerate (56.4%), tioconazole (27.7%), and naftifine (25.1%); and topical corticosteroids were clobetasol propionate (38.5%), methylprednisolone aceponate (36.6%), and mometasone furoate (34.6%). Dermatologists used nitrofurazone and izokonazol nitrate + diflucortolone valerate less frequently compared to non-dermatologists (0% vs. 27.6% and 8.1% vs. 71.7%, respectively; p-values <0.001). Family physicians/general practitioners constituted the largest group selecting clobetasol propionate (28.3%). Conclusion: Physicians in our country predominantly choose fusidic acid and mupirocin as topical antibiotics, aligning with existing literature. However, nitrofurazone, causing contact dermatitis, and corticosteroid-containing antifungals with the potential for complications due to inappropriate use are frequently preferred by non-dermatologist physicians but not by dermatologists. The bold choice of clobetasol propionate, an ultrapotent topical corticosteroid, by family physicians/general practitioners is an important issue to address during medical education and post-graduation.
- 4 October 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 712-720
Open AccessComparison of Topical Treatment Preferences of Physicians in Dermatological Diseases
Objective: Regardless of their specialty, physicians frequently encounter dermatological conditions. We aimed to determine the topical medication choices of physicians for various dermatoses and to identify differences in preferences between dermatologists and non-dermatologist physicians. Methods: Using an online survey, physicians were asked to select three preferred topical antibiotics/antiseptics, antifungals, and corticosteroids when treating a pyoderma, dermatophytosis, or a dermatosis necessitating topical corticosteroid therapy. Statistical analysis was performed using Statistical Package for the Social Sciences v.27. Results: Among 358 physicians, 24.0% were dermatologists, and 76.0% were non-dermatologist physicians. The mean age was 38.40, and the average duration of medical practice was 14.04 years. The most frequently chosen topical antibacterials were fusidic acid (74.3%) and mupirocin (65.9%); topical antifungals were isoconazole nitrate + diflucortolone valerate (56.4%), tioconazole (27.7%), and naftifine (25.1%); and topical corticosteroids were clobetasol propionate (38.5%), methylprednisolone aceponate (36.6%), and mometasone furoate (34.6%). Dermatologists used nitrofurazone and izokonazol nitrate + diflucortolone valerate less frequently compared to non-dermatologists (0% vs. 27.6% and 8.1% vs. 71.7%, respectively; p-values <0.001). Family physicians/general practitioners constituted the largest group selecting clobetasol propionate (28.3%). Conclusion: Physicians in our country predominantly choose fusidic acid and mupirocin as topical antibiotics, aligning with existing literature. However, nitrofurazone, causing contact dermatitis, and corticosteroid-containing antifungals with the potential for complications due to inappropriate use are frequently preferred by non-dermatologist physicians but not by dermatologists. The bold choice of clobetasol propionate, an ultrapotent topical corticosteroid, by family physicians/general practitioners is an important issue to address during medical education and post-graduation.
- Open Access
- 11 January 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (3) , 722-731
Clinical course of psoriasis patients that discontinued biologics during the COVID‐19 pandemic
Background: Since psoriasis is a chronic disease, it is not recommended to discontinue the treatment agents used. However, in real life, the treatment of psoriasis patients may be interrupted for various reasons. During the pandemic period, the treatment of many patients was also interrupted.Objectives: To evaluate relapse and clinical worsening in psoriasis patients whose biological therapy was interrupted during the pandemic and reveal associated factors.Methods: The study included patients aged ≥18 years, who were followed up with moderate and severe chronic psoriasis controlled by the last biological agent [Psoriasis Area Severity Index (PASI) 75 response achieved] but had to discontinue their treatment during the pandemic. The patients' demographic and clinical characteristics, clinical course after the discontinuation of these agents, presence of clinical worsening, and relapse were evaluated. Risk factors were analyzed with the logistic regression analysis.Results: The study included 169 patients, with a mean age of 47.3 ± 14.5 (18–87) years. The mean biologics‐free time was 18.2 ± 12.3 (2–56) weeks. Clinical worsening was detected in 41.4% and relapse in 48.5% of the patients. The significant risk factors for clinical worsening and relapse in both univariate and multivariate analyses were alcohol use during the biologics‐free period, total time off biologics, and the presence of an additional triggering factor. The use of secukinumab and ustekinumab was found to be a protective factor against clinical worsening in multivariate analyses.Conclusion: As the biologics‐free period is prolonged, the likelihood of clinical worsening and relapse increases, therefore, we do not recommend discontinuing biological agents.
- 11 January 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (3) , 722-731
Open AccessClinical course of psoriasis patients that discontinued biologics during the COVID‐19 pandemic
Background: Since psoriasis is a chronic disease, it is not recommended to discontinue the treatment agents used. However, in real life, the treatment of psoriasis patients may be interrupted for various reasons. During the pandemic period, the treatment of many patients was also interrupted.Objectives: To evaluate relapse and clinical worsening in psoriasis patients whose biological therapy was interrupted during the pandemic and reveal associated factors.Methods: The study included patients aged ≥18 years, who were followed up with moderate and severe chronic psoriasis controlled by the last biological agent [Psoriasis Area Severity Index (PASI) 75 response achieved] but had to discontinue their treatment during the pandemic. The patients' demographic and clinical characteristics, clinical course after the discontinuation of these agents, presence of clinical worsening, and relapse were evaluated. Risk factors were analyzed with the logistic regression analysis.Results: The study included 169 patients, with a mean age of 47.3 ± 14.5 (18–87) years. The mean biologics‐free time was 18.2 ± 12.3 (2–56) weeks. Clinical worsening was detected in 41.4% and relapse in 48.5% of the patients. The significant risk factors for clinical worsening and relapse in both univariate and multivariate analyses were alcohol use during the biologics‐free period, total time off biologics, and the presence of an additional triggering factor. The use of secukinumab and ustekinumab was found to be a protective factor against clinical worsening in multivariate analyses.Conclusion: As the biologics‐free period is prolonged, the likelihood of clinical worsening and relapse increases, therefore, we do not recommend discontinuing biological agents.
- Open Access
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022190
Patient Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: A Multicenter Cross-Sectional Study with 1621 Patients
Background: Due to the chronic, recurrent nature of Psoriasis vulgaris (PV) and lack of definitive treatment for the disease, patients often resort to alternative treatments. Physicians seem to have low awareness of this issue. Objectives: To elicit the perceptions of 1,621 PV patients on complementary and alternative medicine (CAM) and examine factors reported to worsen PV. Methods: The patients’ sociodemographic characteristics, Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), disease duration, and severity were recorded, and the patients’ CAM use was questioned in detail. The patients were also asked about factors that worsened PV and their experiences with a gluten-free diet. Results: Of the patients, 56.51% had used CAM. The mean age, illness duration, PASI score,s and DLQI of those using CAM were significantly higher. CAM use were significantly higher in those with facial, genital involvement, and arthralgia/arthritis. The patients mostly referred to CAM when PV became severe (46.4%). Of the CAM users, 45.52% used herbal topicals. The physicians of 67.03% did not inquire whether they used CAM. Of the participants, 37.73% considered that stress worsened their disease. Gluten-free diet did not affect PV symptoms in 52.22%. Conclusions: Patients’ CAM use is often overlooked by dermatologists. Our results showed that more than half the patients used CAM and did not share this information with their physicians. Therefore, the awareness of physicians should be increased and patients should be asked about the use of CAM and directed to the appropriate medical treatment options by physicians.
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022190
Open AccessPatient Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: A Multicenter Cross-Sectional Study with 1621 Patients
Background: Due to the chronic, recurrent nature of Psoriasis vulgaris (PV) and lack of definitive treatment for the disease, patients often resort to alternative treatments. Physicians seem to have low awareness of this issue. Objectives: To elicit the perceptions of 1,621 PV patients on complementary and alternative medicine (CAM) and examine factors reported to worsen PV. Methods: The patients’ sociodemographic characteristics, Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), disease duration, and severity were recorded, and the patients’ CAM use was questioned in detail. The patients were also asked about factors that worsened PV and their experiences with a gluten-free diet. Results: Of the patients, 56.51% had used CAM. The mean age, illness duration, PASI score,s and DLQI of those using CAM were significantly higher. CAM use were significantly higher in those with facial, genital involvement, and arthralgia/arthritis. The patients mostly referred to CAM when PV became severe (46.4%). Of the CAM users, 45.52% used herbal topicals. The physicians of 67.03% did not inquire whether they used CAM. Of the participants, 37.73% considered that stress worsened their disease. Gluten-free diet did not affect PV symptoms in 52.22%. Conclusions: Patients’ CAM use is often overlooked by dermatologists. Our results showed that more than half the patients used CAM and did not share this information with their physicians. Therefore, the awareness of physicians should be increased and patients should be asked about the use of CAM and directed to the appropriate medical treatment options by physicians.
- Open Access
- 1 July 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (3) , e2022143
Habits of using social media and the internet in psoriasis patients
Introduction: Psoriasis significantly affects the patients’ quality of life, which often leads patients to seek online information about this disease. Objectives: To explore the habits of patients with psoriasis related to their use of SM and the internet to obtain information about their disease. Methods: 1,520 patients completed the survey and the Dermatology Life Quality Index (DLQI) questionnaire. The Psoriasis Area Severity Index scores (PASI) and clinical data of the patients were recorded by their physicians. Results: Of the 1,114 patients that reported using social media (SM) and the internet, 48.38% regularly and 31.14% sometimes resorted to obtain information about psoriasis. The use of SM and the internet for psoriasis was statistically significantly higher among young people (p=0.000), those with university or higher education (p=0.009), higher DLQI (p=0.000) and PASI (p=0.011) scores, facial (p=0.050), scalp (p=0.032), hand (p=0.048), genital (p=0.001) and inverse (p=0.000) involvement, and arthralgia/arthritis (p=0.006). The participants mostly used the Google (86%) and Facebook (%41). More than half the participants (62.8%) expected dermatologists to inform society that psoriasis is not contagious. Conclusion: The internet and SM being widely available and offering substantial information to be easily accessed make it very attractive for patients to use these platforms to investigate diseases, including psoriasis. If what is presented on SM conflicts with what the physician says, patients mostly trust the latter, but at the same time, they tend not to share the results of their online inquiries with their physicians.
- 1 July 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (3) , e2022143
Open AccessHabits of using social media and the internet in psoriasis patients
Introduction: Psoriasis significantly affects the patients’ quality of life, which often leads patients to seek online information about this disease. Objectives: To explore the habits of patients with psoriasis related to their use of SM and the internet to obtain information about their disease. Methods: 1,520 patients completed the survey and the Dermatology Life Quality Index (DLQI) questionnaire. The Psoriasis Area Severity Index scores (PASI) and clinical data of the patients were recorded by their physicians. Results: Of the 1,114 patients that reported using social media (SM) and the internet, 48.38% regularly and 31.14% sometimes resorted to obtain information about psoriasis. The use of SM and the internet for psoriasis was statistically significantly higher among young people (p=0.000), those with university or higher education (p=0.009), higher DLQI (p=0.000) and PASI (p=0.011) scores, facial (p=0.050), scalp (p=0.032), hand (p=0.048), genital (p=0.001) and inverse (p=0.000) involvement, and arthralgia/arthritis (p=0.006). The participants mostly used the Google (86%) and Facebook (%41). More than half the participants (62.8%) expected dermatologists to inform society that psoriasis is not contagious. Conclusion: The internet and SM being widely available and offering substantial information to be easily accessed make it very attractive for patients to use these platforms to investigate diseases, including psoriasis. If what is presented on SM conflicts with what the physician says, patients mostly trust the latter, but at the same time, they tend not to share the results of their online inquiries with their physicians.